Latest News and Press Releases
Want to stay updated on the latest news?
-
New proprietary formula for the symptomatic relief of pain and irritated sore throat Initial launch in 3,500 pharmacies in Greece with plans to expand to the UK, Germany, the Netherlands, France,...
-
New Proprietary Dietary Supplement Contributes to NormalBone and Cartilage Health and Joint Flexibility Osteodome Is Second Product to Be Marketed throughout the UKDuring First Quarter 2021 EU...
-
CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
-
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market
CHICAGO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
-
CHICAGO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and...
-
Revenue Increases 48%, Gross profit increased 210% to $2.39 million andEarnings Rise over Same 2019 PeriodGenerics and Nutraceuticals Lead Expansion in EuropeRobotic Automations Enhance Margins and...
-
Seasoned Entrepreneur Has Taken Several Companies from Start-Up to IPO and has served on the boards of several NASDAQ and TSXV companies Appointment Follows Recent Board Selection of Peter Goldstein,...
-
CHICAGO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory...
-
CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six...
-
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year...